An enhancer/promoter combination strengthens the expression of blood-coagulation factor VIII in non-viral expression vectors

Genetics and Molecular Research

Volumn 7, Issue 2, 2008, Pages 314-325

  Picanco Castro V ^a   Russo Carbolante, E M S ^a   Fontes, A M ^a   Fernandes, A C ^a   Covas, D T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coagulation; Enhancer HCR 1 and HCR 2; Human factor VIII; Liver specific promoter; Mammalian cell lines; Plasmid vector

Indexed keywords

ALPHA 1 ANTITRYPSIN; BLOOD CLOTTING FACTOR 8; ELONGATION FACTOR 1ALPHA; PLASMID VECTOR;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENHANCER REGION; EXPRESSION VECTOR; GENE FUSION; GENETIC TRANSFECTION; HEPATIC LOCUS CONTROL REGION 1; HEPATIC LOCUS CONTROL REGION 2; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MAMMALIA;

EID: 47949090032     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol7-2gmr447     Document Type: Article

References (28)

1. Allan CM, Walker D and Taylor JM (1995). Evolutionary duplication of a hepatic control region in the human apolipoprotein E gene locus. Identification of a second region that confers high level and liver-specific expression of the human apolipoprotein E gene in transgenic mice. J. Biol. Chem. 270: 26278-26281.
2. Antonarakis SE, Kazazian HH, Gitschier J, Hutter P, et al. (1995). Molecular etiology of factor VIII deficiency in hemophilia A. Adv. Exp. Med. Biol. 386: 19-34.
3. Burke RL, Pachl C, Quiroga M, Rosenberg S, et al. (1986). The functional domains of coagulation factor VIII:C. J. Biol. Chem. 261: 12574-12578.
4. Chen L, Zhu F, Li J, Lu H, et al. (2007). The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol. Ther. 15: 1856-1862.
5. Fang H, Wang L and Wang H (2007). The protein structure and effect of factor VIII. Thromb. Res. 119: 1-13.
6. Gitschier J, Wood WI, Goralka TM, Wion KL, et al. (1984). Characterization of the human factor VIII gene. Nature 312: 326-330.
7. Hafenrichter DG, Wu X, Rettinger SD, Kennedy SC, et al. (1994a). Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 84: 3394-3404.
8. Hafenrichter DG, Ponder KP, Rettinger SD, Kennedy SC, et al. (1994b). Liver-directed gene therapy: evaluation of liver specific promoter elements. J. Surg. Res. 56: 510-517.
9. Hoyer LW (1994). Hemophilia A. N. Engl. J. Med. 330: 38-47.
10. Kalsheker N, Morley S and Morgan K (2002). Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem. Soc. Trans. 30: 93-98.
11. Kaufman RJ, Wasley LC and Dorner AJ (1988). Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263: 6352-6362.
12. Kaufman RJ, Wasley LC, Davies MV, Wise RJ, et al. (1989). Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol. Cell Biol. 9: 1233-1242.
13. Lam PY, Sia KC, Khong JH, De Geest B, et al. (2007). An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas. Mol. Ther. 15: 1129-1136.
14. Lewis JH, Bontempo FA, Spero JA, Ragni MV, et al. (1985). Liver transplantation in a hemophiliac. N. Engl. J. Med. 312: 1189-1190.
15. Lewis JH, Bontempo FA, Cornell F, Kiss JE, et al. (1987). Blood use in liver transplantation. Transfusion 27: 222-225.
16. Lind P, Larsson K, Spira J, Sydow-Backman M, et al. (1995). Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization. Eur. J. Biochem. 232: 19-27.
17. McGlynn LK, Mueller CR, Begbie M, Notley CR, et al. (1996). Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor VIII gene. Mol. Cell Biol. 16: 1936-1945.
18. Mendel DB, Hansen LP, Graves MK, Conley PB, et al. (1991). HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev. 5: 1042-1056.
19. Meulien P, Faure T, Mischler F, Harrer H, et al. (1988). A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII. Protein Eng. 2: 301-306.
20. Mingozzi F, Liu YL, Dobrzynski E, Kaufhold A, et al. (2003). Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J. Clin. Invest. 111: 1347-1356.
21. Molmenti EP, Perlmutter DH and Rubin DC (1993). Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J. Clin. Invest. 92: 2022-2034.
22. Nash KL, Jamil B, Maguire AJ, Alexander GJ, et al. (2004). Hepatocyte-specific gene expression from integrated lentiviral vectors. J. Gene Med. 6: 974-983.
23. Okuyama T, Huber RM, Bowling W, Pearline R, et al. (1996). Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum. Gene Ther. 7: 637-645.
24. Perlmutter DH, Cole FS, Kilbridge P, Rossing TH, et al. (1985). Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. Proc. Natl. Acad. Sci. U. S. A. 82: 795-799.
25. Pittman DD, Alderman EM, Tomkinson KN, Wang JH, et al. (1993). Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood 81: 2925-2935.
26. Rey-Campos J, Chouard T, Yaniv M and Cereghini S (1991). vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J. 10: 1445-1457.
27. Simonet WS, Bucay N, Lauer SJ and Taylor JM (1993). A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268: 8221-8229.
28. Wion KL, Kelly D, Summerfield JA, Tuddenham EG, et al. (1985). Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317: 726-729.